BetterLife Pharma (BETRF) Total Debt Growth (3y) (2014 - 2026)
BetterLife Pharma (BETRF) Total Debt Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.08% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.52% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -22.87% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -22.30% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.76% |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | 25.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 32.31% |
| Jan 31, 2026 | -42.24% |
| Jul 31, 2025 | 23.26% |
| Apr 30, 2025 | 28.29% |
| Jan 31, 2025 | -64.64% |
| Oct 31, 2024 | 75.73% |
| Jul 31, 2024 | 31.61% |
| Apr 30, 2024 | 22.43% |
| Jan 31, 2024 | 122.06% |
| Oct 31, 2023 | 10.27% |
| Apr 30, 2023 | 486.80% |
| Jan 31, 2023 | 375.57% |
| Oct 31, 2022 | 320.88% |
| Jul 31, 2022 | 107.31% |
| Apr 30, 2022 | -49.16% |
| Jan 31, 2022 | 42.39% |
| Oct 31, 2021 | -60.82% |
| Jul 31, 2021 | -55.44% |
| Apr 30, 2021 | -46.85% |
| Jan 31, 2021 | 30.01% |